Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.82
Delayed Data
As of Jun 26
 +0.76 / +12.54%
Today’s Change
1.51
Today|||52-Week Range
6.92
+234.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues7.4M7.7M13.8M28.5M
 
 
 
 
 
Depreciation And Amortization------1.5M
 
 
 
Operating ExpensesGross Income----------
General Expenses48.0M42.4M42.2M39.5M
 
 
 
 
 
Other Operating Expenses0.004.1M301.0K0.00
 
 
 
Research And Development38.7M32.9M33.7M32.9M
 
 
 
 
 
Total Operating Expenses9.3M9.5M8.5M41.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.5M-38.8M-28.6M-12.5M
 
 
 
 
 
Extraordinary Charge-------386.0K
 
 
Interest Expense On Debt5.0M6.2M4.7M4.7M
 
 
 
 
 
Other Expenses-424.0K275.0K-758.0K134.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-45.9M-44.7M-34.2M-17.3M
 
 
 
 
 
Net Income-45.9M-44.7M-34.2M-17.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.2M87.1M87.1M87.2M
 
 
 
 
 
Shares To Calculate EPS Diluted87.2M87.1M87.1M87.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.53-$0.51-$0.39-$0.20
 
 
 
 
 
EPS Diluted-$0.53-$0.51-$0.39-$0.20